Medical/Pharmaceuticals

EmeTerm, by WAT Medical, an easy solution for Cyber Sickness

VANCOUVER, April 13, 2020 /PRNewswire/ -- WAT Medical Enterprise Ltd. conducted an investigation on solutions to cyber sickness (a form of nausea-induced vomiting). WAT Medical team has been studying has achieved positive results with the use of EmeTerm. Based on a large number of experimental te...

2020-04-13 21:00 1396

Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions

SHANGHAI and MELBOURNE, Australia, April 13, 2020 /PRNewswire/ -- Antengene Corporation today announced the appointment of Mr. Thomas Karalis as Head of Asia Pacific Regions. In this position, Tom will be responsible for the commercialization of Antengene products inAustralia, New Zealand, S. Kor...

2020-04-13 20:00 3348

Ascletis Receives IND Approval for its HIV Drug ASC09F

HANGZHOU and SHAOXING, China, April 13, 2020 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX code: 1672) announces today that it received IND approval from National Medical Products Administration (NMPA) for its human immunodeficiency virus (HIV) protease inhibitor ASC09F (ASC09/Ritonavir Fixed-Dose C...

2020-04-13 20:00 3503

Cyient Receives ISO 13485 Quality Certification for ASIC Design and Supply

The new certification is in addition to the ISO 13485 certifications the company has had for engineering since 2009 and manufacturing since 2007 and is a testament to its expertise in developing advanced ICs for the MedTech market. HYDERABAD, India, April 13, 2020 /PRNewswire/ -- Cyient, a global...

2020-04-13 17:23 2130

AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility

TOKYO, April 10, 2020 /PRNewswire/ -- AGC Inc. (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, has announced its decision to expand facilities at its synthetic pharmaceutical (*1) CDMO (*2) business subsidiary, AGC Pharma Chemicals Europe S. L. U., headquartered i...

2020-04-10 14:00 2248

Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal anti...

2020-04-10 11:39 2673

JNCCN: Improving COVID-19 Safety for Cancer Patients and Healthcare Providers

PLYMOUTH MEETING, Pennsylvania, April 9, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019 (COVI...

2020-04-09 20:35 1769

Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS

GERMANTOWN, Maryland, April 9, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues a...

2020-04-09 20:00 3386

Merck and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

Not intended for US-, Canada- and UK-based media  -  Breakthrough Therapy Designation and Submission based on positive Phase III JAVELIN Bladder 100 study results -  Supplemental Biologics License Application being reviewed under FDA Real-Time Oncology Review (RTOR) pilot program -  JAVELIN B...

2020-04-09 18:00 5034

World-First Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight

SYDNEY, April 9, 2020 /PRNewswire/ -- A world-first trial will see researchers from Austin Health and theUniversity of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The trial will be led by Austin Health's Dr Joseph Ischia and Dr Oneel Patel from the Department ...

2020-04-09 15:57 1385

EHR Investments Increase as Governments and Healthcare Authorities Focus on Interoperability

Europe will see more partnerships for integrated care from the evolution of electronic health records, finds Frost & Sullivan LONDON, April 9, 2020 /PRNewswire/ -- The electronic medical record (EMR) market is likely to register impressive growth acrossEurope as it evolves into a morecomprehensi...

2020-04-09 15:50 2176

Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis

* The Interim data showed that 3 out of 9 evaluable patients on BBT-401 responded with more than 30% reduction in Total Mayo Score or 25% reduction in Partial Mayo Score * Safety and tolerability profiles remain consistent with results from Phase I trial in healthy volunteers SEONGNAM, South ...

2020-04-09 15:14 1403

Qiming Venture Partners Raises $1.1 Billion Fund VII

SHANGHAI, BEIJING, HONG KONG and SHENZHEN, China, April 9, 2020 /PRNewswire/ -- Qiming Venture Partners today announced the closing of Qiming Venture Partners Fund VII, a new$1.1B fund focused on early stage Healthcare and TMT investments. Qiming is honored to have continued strong support from i...

2020-04-09 09:18 4107

United Imaging Announces Rapid CT Deployment to Help Expand Capacity at Maimonides Medical Center

HOUSTON, April 8, 2020 /PRNewswire/ -- United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that it has installed a transportable CT scanner at the request of Maimonides Medical Center, the largest hospital inBrooklyn, New York, on the front lines of t...

2020-04-08 20:00 1250

Samsung Biologics named Champion in 2020 CMO Leadership Awards

SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it has been awarded the 2020 CMO Leadership Awards for its excellence in the Capabilities, Compatibility, Quality, Reliability, and Service categories across Big Pharma and Overall (combined Big and Sm...

2020-04-08 20:00 1283

China-based Asclepius Metidec helps solve ventilator shortage with its innovative device

SHANGHAI, April 8, 2020 /PRNewswire/ -- An innovative technology-powered medical device developed by Chinese medical equipment provider Asclepius Metidec has been successfully used in the treatment of patients with confirmed COVID-19. The hydrogen oxygen nebulizer, as a result of nine years of r...

2020-04-08 17:35 1453

Aetna International Announces Waiver for Cost-sharing, Co-pay and Deductibles for COVID-19-related Inpatient Treatment

SINGAPORE, April 8, 2020 /PRNewswire/ -- Aetna International today announced it is waiving cost-sharing, co-pay and other deductibles for inpatient hospital admissions related to COVID-19, as part of several additional steps to help international medical insurance members access the care that t...

2020-04-08 16:52 2725

Ping An Good Doctor Launches Global Medical Consultation Platform in 24/7 Support of Anti-COVID-19 Efforts

SHANGHAI, April 8, 2020 /PRNewswire/ -- The global COVID-19 situation has been deteriorating day by day, with the world's confirmed cases totalling 1.41 million and death exceeding 80,000 until6am on 8 April. Today, Ping An Healthcare and Technology Company Limited("Ping An Good Doctor"; stock co...

2020-04-08 16:20 8533

Mindray Chairman's Statement on Efforts to Combat COVID-19

SHENZHEN, China, April 8, 2020 /PRNewswire/ -- Mindray (SZSE: 300760) -- As COVID-19 is casting a dark shadow over people's health, healthcare providers around the world are fighting relentlessly against the virus. We salute all medical staff for their valiant efforts to save patients' lives and ...

2020-04-08 15:53 2184

Rapid Medical Announces Ahead of Schedule Completion of Patient Enrollment for the TIGER Clinical Study for TIGERTRIEVER Thrombectomy Device

YOKNEAM, Israel, April 8, 2020 /PRNewswire/ -- Rapid Medical , a company focused on the development of next generation neurovascular interventional devices, has announced that it has completed enrollment in the TIGER (Treatment with Intent to Generate R eperfusion) ...

2020-04-08 08:00 2467
1 ... 580581582583584585586 ... 610

Week's Top Stories